China Cuts Drug Approval Lag but Reimbursement Gaps Persist for Overseas New Medicines
A 16-year analysis of 361 overseas new drugs shows China's regulatory reforms cut approval lag and reimbursement delays, but biologics, ...
Tag: oncology
Early PET/CT Scan Predicts Which HER2-Positive Breast Cancers Will Vanish Before Surgery
A prospective study finds that 68Ga-HER2 PET/CT scans after just two cycles of neoadjuvant therapy can predict which HER2-positive breast ...
Newer Anti-Nausea Drug Beats Ondansetron in Preventing Chemotherapy Vomiting, Review Finds
A new meta-analysis of eight randomised controlled trials finds that palonosetron significantly outperforms ondansetron in preventing vomiting during the acute, ...
EU Rules Are Suffocating Academic Cancer Trials, Researchers Warn
European oncologists document how clinical-trial regulation has driven academic treatment optimization studies toward collapse and propose a risk-adapted framework tied ...
Immune Therapy’s Hidden Cost: Nearly Three in Ten Lung Cancer Patients Face Severe Financial Toxicity
A latent profile analysis of 331 lung cancer patients receiving immunotherapy identified three distinct financial toxicity groups, with lower income, ...
Digital Twins Promise to Map the Future of Medicine
Medicine is quietly acquiring a new kind of patient: one made entirely of data and mathematics. Digital twins, computational replicas ...
Why the Immune System Fails Some Bladder Cancers and How Scientists Are Fighting Back
A new review explains why BCG immunotherapy fails in some bladder cancer patients and outlines emerging combination strategies designed to ...
When Patients Rate Their Own Care: EHR-Embedded Symptom Scores Show Real Gains — and Real Limits
Chronic diseases now kill roughly 41 million people every year, and the daily grind of managing them — diabetes, heart ...
Chemotherapy Curability May Trace Back to Highly Sensitive Cells of Origin
A new hypothesis review argues that chemotherapy-curable cancers inherit their extraordinary drug sensitivity from healthy, transient precursor cells engaged in ...
Lower Lenvatinib Starting Doses Show No Clear Advantage in Advanced Endometrial Cancer
A new systematic review and meta-analysis finds that starting lenvatinib below 20 mg with pembrolizumab neither clearly preserves tumor response ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!